Qure.ai, an artificial intelligence provider for healthcare has partnered with Teleradiology Solutions, global pioneer in remote radiology interpretation and telehealth, along with Telerad Tech to enable smarter and faster diagnoses of X-ray and CT-scan data, and reduce costs.
Through this partnership, Qure.ai’s chest X-ray technology will be integrated with Telerad Tech’s proprietary RIS PACS platform RADSpa that TRS uses to provide teleradiology services globally.
“At Qure.ai, we are expanding the reach of our AI algorithms to help medical professionals deliver better outcomes to their patients. TRS and Telerad Tech are pioneers in their respective domains, and we are excited about the impact this partnership will have on the millions of patients’ lives they touch,” said Prashant Warier, Co-Founder and CEO, Qure.ai.
TRS has reported scans for over five million patients since inception in 2002, and currently caters to the requirements of 150 hospitals and healthcare centers in more than 20 countries, including the United States, Singapore, Nigeria, Tanzania, Uganda, Maldives and India.
Telerad Tech’s RADSpa platform is deployed in 24 countries and has processed more than 20 million studies and billions of images. RADSpa is FDA approved and CE certified.
TRS’s clinical expertise and Telerad Tech’s RADSpa platform consolidates radiology report information from diverse sources so radiologists can review these reports from anywhere and anytime.
“Making sure that doctors and hospitals have the necessary and highest quality information has to be the topmost priority. Diseases that are of public health importance worldwide such as tuberculosis, are within our focus of interest with a goal of providing high quality diagnostics to facilitate early detection. Qure.ai, TRS & T2 have a shared vision when it comes to achieving this goal, and we strongly believe this will be highly beneficial for doctors, hospitals and patients alike,” said Dr Arjun Kalyanpur, CEO, Teleradiology Solutions.
Qure.ai’s chest X-ray solution can automatically screen for abnormal chest X-rays and tuberculosis. Qure.ai’s automated reads can have a substantial impact on the screening protocol for tuberculosis globally.